BioMarket Group - Market Research Update W29 2008

This report is written for you to identify your competition and understand which targeting strategies are at work within anti-angiogenic drug development in oncology. It allows you to pin-point which competitors drugs’ clinical out-come may have bearing on your own drug development and who are developing sequels to blockbuster drugs. This report also helps you to locate white-spots in the competitive landscape, giving you little or no competition. Conversly it may reveal unexpected competition for you.

Neurological Disorders

The Antipsychotics Market Insight & Analysis 2008

This in-depth market analysis examines prospects for antipsychotic drugs right through to 2012, including sales forecasts for leading products.

Parkinsons Disease Market analysis and forecasts, 2008-2012, 2017 & 2022

With key some PD drugs expected to lose patent expiration in the near-term, visiongain predicts that the entry of new products will be inevitable. But which products will be successful and how much revenue will they generate?

eHealth

eHealth Insight Series: Reaching Doctors and Patients Through New Digital Media

This report explores the challenges facing Pharma´s communication models and assesses current online strategies as well as novel strategies that could be adopted to convey messages to doctors and patients through emerging digital media channels.

BioMarket is an aggregator of global business intelligence in the biotech and life science industry. Companies turn to BioMarket for in-depth industry research, global business information and independent equity analysis.

Find out more about us or contact us.

Bioworld is an ever expanding registry of web addresses and presently holds more than 5,000 URLs. Biotech and pharma companies are sorted on country basis, and more than 40 countries.

Go to Bioworld.

[ Back ]